Compare KMB & IDXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KMB | IDXX |
|---|---|---|
| Founded | 1910 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Containers/Packaging | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.5B | 55.0B |
| IPO Year | N/A | 1991 |
| Metric | KMB | IDXX |
|---|---|---|
| Price | $101.15 | $686.36 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 10 |
| Target Price | $128.08 | ★ $700.50 |
| AVG Volume (30 Days) | ★ 5.5M | 525.8K |
| Earning Date | 01-27-2026 | 02-02-2026 |
| Dividend Yield | ★ 4.99% | N/A |
| EPS Growth | N/A | ★ 21.65 |
| EPS | 5.91 | ★ 12.60 |
| Revenue | ★ $19,724,000,000.00 | $4,167,411,000.00 |
| Revenue This Year | N/A | $12.15 |
| Revenue Next Year | $2.40 | $8.72 |
| P/E Ratio | ★ $17.09 | $54.64 |
| Revenue Growth | ★ 11.62 | 8.39 |
| 52 Week Low | $99.22 | $356.14 |
| 52 Week High | $150.45 | $769.98 |
| Indicator | KMB | IDXX |
|---|---|---|
| Relative Strength Index (RSI) | 37.84 | 42.78 |
| Support Level | $101.92 | $676.06 |
| Resistance Level | $101.75 | $711.68 |
| Average True Range (ATR) | 1.25 | 14.96 |
| MACD | 0.10 | -3.61 |
| Stochastic Oscillator | 31.39 | 22.87 |
With more than half of its sales from personal care and another third from consumer tissue products, Kimberly-Clark is a leading manufacturer in the tissue and hygiene realm. Its brand mix includes Huggies, PullUps, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates in the professional segment, partnering with businesses to provide safety and sanitary offerings for the workplace. Kimberly-Clark generates just over half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America. It intends to add Kenvue's consumer health portfolio to its mix in the second half of calendar year 2026.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.